COMP <GO>
ANAB vs GHRS // OPERATING MARGIN
AnaptysBio Inc. (NASDAQ) VS. GH Research PLC (NASDAQ) • 15-METRIC TALLY: ANAB 0
— GHRS 2
■ METRIC PARITY
LAST: $48.64 (-3.68%) • MKT CAP: $1.44B
operating-margins
75.00%
LAST: $21.50 (+3.82%) • MKT CAP: $1.47B
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANAB VS. GHRS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANAB | GHRS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.36% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | 75.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -5.60% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 157.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.0 | 51.6 | -3.60 | GHRS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.44B | $1.47B | -$33.8M | GHRS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANAB REV | GHRS REV | ANAB GROSS % | GHRS GROSS % | ANAB FCF | GHRS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $234.6M | — | — | — | $19.6M | — |
| FY 2024 | $91.3M | — | — | — | -$135.7M | — |
| FY 2023 | $17.2M | — | — | — | -$120.8M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANAB // BETA —
GHRS // BETA —